Septerna (SEPN) Accumulated Depreciation & Amortization (2023 - 2026)
Septerna's quarterly Accumulated Depreciation & Amortization came in at $400000.0 in Q1 2026, little changed year-on-year from $400000.0 in Q1 2025, and down 75.0% quarter-over-quarter from $1.6 million in Q4 2025.
Septerna has reported Accumulated Depreciation & Amortization for 4 years, with the latest figure at $400000.0 in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Depreciation & Amortization changed 0.0% year-over-year to $400000.0; the trailing twelve-month figure through Mar 2026 stood at $400000.0 (changed 0.0% YoY), and the FY2025 full-year result was $1.6 million, up 14.29% from the prior year.
- Accumulated Depreciation & Amortization for Q1 2026 stood at $400000.0, down from $1.6 million in the prior quarter.
- The five-year high for Accumulated Depreciation & Amortization was $1.6 million in Q4 2025, with the low at $200000.0 in Q3 2023.
- Average Accumulated Depreciation & Amortization over 4 years is $690909.1, with a median of $400000.0 recorded in 2025.
- Year-over-year, Accumulated Depreciation & Amortization surged 400.0% in 2024 and sank 60.0% in 2025.
- Tracing SEPN's Accumulated Depreciation & Amortization over 4 years: stood at $800000.0 in 2023, then soared by 75.0% to $1.4 million in 2024, then gained by 14.29% to $1.6 million in 2025, then slumped by 75.0% to $400000.0 in 2026.
- The last three Accumulated Depreciation & Amortization figures came in at $400000.0 (Q1 2026), $1.6 million (Q4 2025), and $400000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Septerna | 1.34 Bn | 1.34 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 400,000.00 |
| Mar 31, 2026 | 400,000.00 |
| Dec 31, 2025 | 1.60 Mn |
| Dec 31, 2025 | 1.60 Mn |
| Sep 30, 2025 | 400,000.00 |
| Sep 30, 2025 | 400,000.00 |
| Jun 30, 2025 | 800,000.00 |
| Jun 30, 2025 | 800,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Mar 31, 2025 | 400,000.00 |
| Dec 31, 2024 | 1.40 Mn |
| Dec 31, 2024 | 1.40 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Sep 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 300,000.00 |
| Jun 30, 2024 | 300,000.00 |
| Mar 31, 2024 | 300,000.00 |
| Mar 31, 2024 | 300,000.00 |
| Dec 31, 2023 | 800,000.00 |
| Dec 31, 2023 | 800,000.00 |
| Sep 30, 2023 | 200,000.00 |
| Sep 30, 2023 | 200,000.00 |